Cargando…

Efficacy and safety of radiation therapy in advanced adrenocortical carcinoma

BACKGROUND: International guidelines emphasise the role of radiotherapy (RT) for the management of advanced adrenocortical carcinoma (ACC). However, the evidence for this recommendation is very low. METHODS: We retrospectively analysed all patients who received RT for advanced ACC in five European c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kimpel, Otilia, Schindler, Paul, Schmidt-Pennington, Laura, Altieri, Barbara, Megerle, Felix, Haak, Harm, Pittaway, James, Dischinger, Ulrich, Quinkler, Marcus, Mai, Knut, Kroiss, Matthias, Polat, Bülent, Fassnacht, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938283/ https://www.ncbi.nlm.nih.gov/pubmed/36482186 http://dx.doi.org/10.1038/s41416-022-02082-0

Ejemplares similares

Adjuvant platinum-based chemotherapy in radically resected adrenocortical carcinoma: a cohort study
por: Kimpel, Otilia, et al.
Publicado: (2021)

Management of Patients With Glucocorticoid-Related Diseases and COVID-19
por: Chifu, Irina, et al.
Publicado: (2021)

What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered Question
por: Basile, Vittoria, et al.
Publicado: (2021)

Outcome after resection of Adrenocortical Carcinoma liver metastases: a retrospective study
por: Baur, Johannes, et al.
Publicado: (2017)

Epithelial and Mesenchymal Markers in Adrenocortical Tissues: How Mesenchymal Are Adrenocortical Tissues?
por: Sbiera, Iuliu, et al.
Publicado: (2021)

Modified GRAS Score for Prognostic Classification of Adrenocortical Carcinoma: An ENSAT Multicentre Study
por: Elhassan, Yasir, et al.
Publicado: (2021)

Metabolic heterogeneity in adrenocortical carcinoma impacts patient outcomes
por: Wang, Qian, et al.
Publicado: (2023)

Results of the ADIUVO Study, the First Randomized Trial on Adjuvant Mitotane in Adrenocortical Carcinoma Patients
por: Terzolo, Massimo, et al.
Publicado: (2021)

THU617 Prolonged Exposure To Target Mitotane Concentrations Is Associated With Better Recurrence-free Survival In Patients With Adrenocortical Carcinoma On Adjuvant Treatment
por: Puglisi, Soraya, et al.
Publicado: (2023)

Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study
por: Terzolo, Massimo, et al.
Publicado: (2023)

Role of FGF Receptors and Their Pathways in Adrenocortical Tumors and Possible Therapeutic Implications
por: Sbiera, Iuliu, et al.
Publicado: (2021)

Interplay between glucocorticoids and tumor-infiltrating lymphocytes on the prognosis of adrenocortical carcinoma
por: Landwehr, Laura-Sophie, et al.
Publicado: (2020)

SUN-350 Sterol-O-Acyl Transferase 1 Protein Expression Alone Is Not Sufficient to Predict Response to Mitotane Treatment in Adrenocortical Carcinoma
por: Weigand, Isabel, et al.
Publicado: (2019)

S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study
por: Elhassan, Y S, et al.
Publicado: (2021)

Coincidence of primary adrenocortical carcinoma and melanoma: three CASE reports
por: Ko, Ye Lynn, et al.
Publicado: (2023)

Effects of Germline CYP2W1*6 and CYP2B6*6 Single Nucleotide Polymorphisms on Mitotane Treatment in Adrenocortical Carcinoma: A Multicenter ENSAT Study
por: Altieri, Barbara, et al.
Publicado: (2020)

Impact of the Chemokine Receptors CXCR4 and CXCR7 on Clinical Outcome in Adrenocortical Carcinoma
por: Chifu, Irina, et al.
Publicado: (2020)

Past, Present and Future of Epigenetics in Adrenocortical Carcinoma
por: Ettaieb, Madeleine, et al.
Publicado: (2020)

Health-Related Quality of Life in Adrenocortical Carcinoma
por: Steenaard, Rebecca V., et al.
Publicado: (2019)

FGF/FGFR signaling in adrenocortical development and tumorigenesis: novel potential therapeutic targets in adrenocortical carcinoma
por: Tamburello, Mariangela, et al.
Publicado: (2022)

Metyrapone Versus Osilodrostat in the Short-Term Therapy of Endogenous Cushing’s Syndrome: Results From a Single Center Cohort Study
por: Detomas, Mario, et al.
Publicado: (2022)

Targeted Gene Expression Profile Reveals CDK4 as Therapeutic Target for Selected Patients With Adrenocortical Carcinoma
por: Liang, Raimunde, et al.
Publicado: (2020)

CYP2W1 Is Highly Expressed in Adrenal Glands and Is Positively Associated with the Response to Mitotane in Adrenocortical Carcinoma
por: Ronchi, Cristina L., et al.
Publicado: (2014)

Adrenocortical Carcinoma Treatment in the Netherlands: An Analysis From the Netherlands Cancer Registry From 2014 to 2019
por: Steenaard, Rebecca, et al.
Publicado: (2021)

SUN-348 Cabozantinib in Advanced Adrenocortical Carcinoma: Rationale and Protocol of Two Phase II Clinical Trials
por: Kroiss, Matthias, et al.
Publicado: (2019)

SAT-354 Characterization of Cell Death Induced by SOAT1 Inhibition in Adrenocortical Carcinoma Cells
por: Weigand, Isabel, et al.
Publicado: (2019)

Patient and Partner Perspectives on Health-Related Quality of Life in Adrenocortical Carcinoma
por: Steenaard, Rebecca V, et al.
Publicado: (2020)

GnRH antagonist treatment of malignant adrenocortical tumors
por: Doroszko, Milena, et al.
Publicado: (2018)

Heat Shock Protein 90 as a Prognostic Marker and Therapeutic Target for Adrenocortical Carcinoma
por: Siebert, Claudia, et al.
Publicado: (2019)

Prognostic Role of Targeted Methylation Analysis in Paraffin-embedded Samples of Adrenocortical Carcinoma
por: Lippert, Juliane, et al.
Publicado: (2022)

Urine Steroid Metabolomics as a Novel Tool for Detection of Recurrent Adrenocortical Carcinoma
por: Chortis, Vasileios, et al.
Publicado: (2019)

SUN-LB22 PLK1 as a New Treatment Target for Adrenocortical Carcinoma
por: Smith, Gabrielle, et al.
Publicado: (2020)

Livin/BIRC7 expression as malignancy marker in adrenocortical tumors
por: Altieri, Barbara, et al.
Publicado: (2016)

Evaluation of the Molecular Pathogenesis of Adrenocortical Tumors by Whole-Genome Sequencing
por: Neininger, Kerstin, et al.
Publicado: (2021)

Sunitinib Inhibits Cell Proliferation and Alters Steroidogenesis by Down-Regulation of HSD3B2 in Adrenocortical Carcinoma Cells
por: Kroiss, Matthias, et al.
Publicado: (2011)

Identifying New Potential Biomarkers in Adrenocortical Tumors Based on mRNA Expression Data Using Machine Learning
por: Marquardt, André, et al.
Publicado: (2021)

Active steroid hormone synthesis renders adrenocortical cells highly susceptible to type II ferroptosis induction
por: Weigand, Isabel, et al.
Publicado: (2020)

SUN-211 Active Steroid Hormone Synthesis Renders Adrenocortical Cells Highly Susceptible to Type II Ferroptosis Induction
por: Weigand, Isabel, et al.
Publicado: (2020)

Nuclear DNA content and morphological characteristics in the prognosis of adrenocortical carcinoma.
por: Haak, H. R., et al.
Publicado: (1993)

Outcome of CRH stimulation test and overnight 8 mg dexamethasone suppression test in 469 patients with ACTH-dependent Cushing’s syndrome
por: Detomas, Mario, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6up71t4ubhglfddg9mndloh23f